SecBot SecBot
Insider Cluster (7 insiders) ·Filed Mar 16, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 4/10
Horizondays Processed8mo ago
Insider cluster: 3 insiders, $0.6M total
Actionable Insight • Neutral

The selling is minimal relative to market cap ($23.2B) and appears tied to option exercises and tax obligations, not negative sentiment. Traders should monitor for follow-up filings or commentary around earnings or pipeline updates, but no immediate signal from this cluster.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$540.02
T+0 close · Mar 16, 2026 · via day close
Latest settled
+1.00%
T+60 · $545.40
Vs SPY
−8.99%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 17 $540.02entry
  2. T+1 · 8mo ago −1.79%α −0.40% · $530.35
  3. T+5 · 8mo ago −1.52%α +1.11% · $531.82
  4. T+20 · 7mo ago +6.96%α +2.61% · $577.58
  5. T+60 · 5mo ago +1.00%α −8.99% · $545.40
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Multiple United Therapeutics insiders, including CEO Martine Rothblatt and CFO James Edgemond, engaged in significant stock transactions over the past week, primarily involving derivative exercises and tax-related share withholdings. The open-market sales totaled $684,416, while non-cash transactions (exercises and tax withholdings) amounted to over $10.1 million in value. This cluster reflects routine equity settlement activity rather than strategic selling.

Key Financial Metrics

Direction
selling
Total Value
$684.4K
Insiders
7

Key Facts

  • CEO Martine Rothblatt sold 1,009 shares for $537,803 across three open-market transactions; also exercised derivatives on 61,499 shares at $146.03 strike price
  • CFO James Edgemond had $2.51M in tax withholding (F transaction) and exercised derivatives on 10,380 shares (non-cash)
  • COO Michael Benkowitz had $4.20M in tax withholding (F transaction)
  • EVP Paul Mahon sold 753 shares for $397,184 and exercised derivatives on 17,195 shares
  • Director Judy Olian sold 200 shares for $107,088; Director Jan Malcolm sold 45 shares for $24,008
  • Total open-market sales: $684,416 across 4 insiders
  • Total non-cash transactions (M, F, A): over $10.1 million in value
  • All transactions occurred between March 15–19, 2026

Financial Impact

$684,416 in net open-market selling; $10.1M in non-cash derivative settlements and tax withholdings

insider ownershipshare counteffective tax cost

Risk Factors

  • Perception risk from high-dollar tax withholdings, though common in biotech executives with large option grants
  • Concentration of transactions around CEO and CFO could draw scrutiny if pattern continues

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CONTEXT: Insider Cluster Data (20 trades, 7d window)cluster-UTHR-1773952260021

Track record

123 reports on UTHR

Performance horizon

4 of 9 bullish or bearish reports moved the stock their way by T+5. Best: +10.30% at T+20 after the Oct 14, 2026 report. 5 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 3/10 Entry price pending
  2. Nov 13, 20263d ago Insider Cluster Bearish 4/10 Entry $597.50 Now $587.88 +1.61% settles Nov 23
  3. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $591.17 Now $587.88 −0.56% settles Nov 20
  4. Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $595.66 Now $587.88 −1.31% settles Nov 18
  5. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  6. Nov 9, 20267d ago 144 Neutral 2/10 Entry $588.61 Now $587.88 −0.12% settles Nov 17
  7. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $582.46 to $587.88 Now $587.88 +0.93% ▲ +0.93% +2.62% vs SPY
  8. Nov 5, 202611d ago Insider Cluster Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  9. Nov 5, 202611d ago 144 Neutral 2/10 Entry $562.02 to $591.17 Now $587.88 +4.60% ▲ +5.19% +2.59% vs SPY
  10. Nov 4, 202612d ago SC 13G/A Neutral 2/10 Entry $565.72 to $593.31 Now $587.88 +3.92% ▲ +4.88% +1.59% vs SPY
Showing 10 of 123

US Market Status

Market Closed · Opens Wed (11h 9m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 19, 2026